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Abstract
A noninvasive method for molecular imaging of T-cell
activity in vivo would be of considerable value. It would
aid in understanding the role of specific genes and
signal transduction pathways in the course of normal
and pathologic immune responses, and could elucidate
temporal dynamics and immune regulation at different
stages of disease and following therapy. We developed
and assessed a novel method for monitoring the T-cell
receptor (TCR) -dependent nuclear factor of activated T
cells (NFAT) -mediated activation of T cells by optical
fluorescence imaging (OFI ) and positron emission
tomography (PET). The herpes simplex virus type 1
thymidine kinase/green fluorescent protein [HSV1-tk /
GFP (TKGFP ) ] dual reporter gene was used to monitor
NFAT-mediated transcriptional activation in human
Jurkat cells. A recombinant retrovirus bearing the
NFAT-TKGFP reporter system was constructed in
which the TKGFP reporter gene was placed under
control of an artificial cis -acting NFAT-specific en-
hancer. Transduced Jurkat cells were used to establish
subcutaneous infiltrates in nude rats. We demonstrated
that noninvasive OFI and nuclear imaging of T-cell
activation is feasible using the NFAT-TKGFP reporter
system. PET imaging with [124I ]FIAU using the NFAT-
TKGFP reporter system is sufficiently sensitive to detect
T-cell activation in vivo. PET images were confirmed by
independent measurements of T-cell activation (e.g.,
CD69) and induction of GFP fluorescence. PET imaging
of TCR-induced NFAT-dependent transcriptional activ-
ity may be useful in the assessment of T cell responses,
T-cell–based adoptive therapies, vaccination strategies
and immunosuppressive drugs. Neoplasia (2001) 3,
480–488.
Keywords: molecular imaging, T - cell activation, herpes virus type 1 thymidine kinase,
FIAU, PET.
Introduction
The analysis of molecular and biochemical events occurring
in vivo during T-cell activation requires invasive tissue
sampling. The recourse to invasive procedures often
hinders and eventually precludes serial studies in the same
subject, and does not provide spatial information concern-
ing activated T-cell localization. By limiting studies to
biopsy material, such investigations fail to provide a
whole-body evaluation of developing immune responses.
New technologies are needed to permit biochemical
investigation in situ and repeatedly over time if necessary.
Noninvasive whole-body imaging of T-cell activity would be
of a considerable value; it would allow identification of sites
and temporal dynamics of T-cell activation and provide a
way to monitor trafficking of T cells during primary and
memory responses. To visualize T-cell activation in vivo,
we developed a T-cell receptor (TCR) -dependent,
nuclear factor of activated T cells (NFAT) -sensitive
TKGFP dual - reporter system that could be imaged using
positron emission tomography (PET) [1–4] and whole-body
optical fluorescence imaging (OFI) [5 ] .
TCR interactions with MHC–peptide complexes
expressed on antigen-presenting cells initiate T-cell activa-
tion, resulting in transcription mediated by several factors
including NFAT. The TCR-specific NFAT family of tran-
scription factors contains five distinct members. NFATs 1 to
4 share a highly conserved DNA binding domain and
contribute to regulating a number of target genes, including
interleukin 2 ( IL-2) and other cytokines [6–9] . Their
transcriptional activity is dependent on cytoplasmic dephos-
phorylation by the calcium-dependent serine phosphatase
calcineurin and subsequent nuclear translocation, a process
arrested by the calcineurin inhibitors Cyclosporin A and
FK506 [6] .
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RESEARCH ARTICLE
In this paper, we describe the development of a
recombinant self - inactivating retroviral vector encoding
TKGFP and its use to monitor Jurkat T-cell activation by
fluorescent microscopy, fluorescence-activated cell sorting
(FACS) and radiotracer assays. We demonstrate that the
same reporter system can be used to noninvasively monitor
TCR- induced NFAT-mediated activation of subcutaneous
Jurkat T-cell infiltrates in vivo by OFI and PET imaging.
Materials and Methods
Generation of Cis-NFAT/TKGFP and TKGFP Reporter
Vectors
The TKGFP fusion gene and the SFG-TKGFP retroviral
vector, which constitutively expresses TKGFP, were
described previously [10] . To generate the Cis -NFAT/
TKGFP vector, the TKGFP cDNA was cloned into the
plasmid pNFAT-Luc (Stratagene, La Jolla, CA), replacing
the luciferase gene. The BamHI–NotI fragment containing
the NFAT enhancer element, TATA-box, and TKGFP was
then subcloned into the multicloning site of pLXSN (Clon-
tech, Palo Alto, CA), 50 to the neomycin phosphotransferase
gene and the SV40 promoter. The NheI–NheI fragment
containing the pBR322 backbone and most of the viral 30LTR
was replaced with pUC19 and a crippled 30LTR (NheI–SacI
deletion) to generate dxNFATtgn. To potentiate NFAT-
induced TKGFP expression, the adaptor containing the
sequence of the minimal cytomegalovirus (CMV) promoter
( from pBI-GL vector, Clontech) was introduced in the
dxNFATtgn vector between the XbaI and EcoRI sites,
replacing the original TATA-box, to create dcmNFATtgn. A
negative control vector, termed dxRtgn, was constructed by
replacing the NFAT responsive element with a random
sequence of the same length. DNA (10 g) was transfected
into the GPG29 packaging cell line as previously described
using the calcium phosphate method [11] . Vesicular
stomatitis virus G-protein (VSV-G) –pseudotyped retroviral
particles were used as cell - free viral stocks to transduce
Jurkat cells.
Cell Lines
Jurkat cells bearing a functional TCR were kindly provided
by Dr. P. King (Hospital for Special Surgery, Cornell
University, NY) and grown in suspension in RPMI-1640
media supplemented with 10% fetal calf serum, L-glutamine,
penicillin, and streptomycin ( Invitrogen, Carlsbad, CA). The
in vitro transduction of Jurkat cells with retroviral vectors was
accomplished by exposing the cells to a filtered (0.45 m)
culture medium obtained from the vector producer cells for
24 hours in the presence of polybrene (8 g/ml) . Two days
later, the media was supplemented with 1 mg/ml of G418
( Invitrogen) to select for transduced cells, and grown either
as a bulk transduced culture or cloned by limiting dilution in
96-well plates. Clones were re-analyzed by FACS and
clones with low basal levels of green fluorescent protein
(GFP) fluorescence and high inducible levels after stim-
ulation were selected.
Stimulation of Jurkat Cells In Vitro
Nonspecific stimulation transduced and wild- type Jurkat
cells was performed with phorbol 12-myristate 13-acetate
(PMA) 10 ng/ml and ionomycin 2.2 m/l (Sigma, St.
Louis, MO). TCR-specific stimulation of the cells was
performed using plates precoated with anti–human CD3
antibody (1 g/ml, Pharmingen, San Diego, CA) and
soluble anti–human CD28 antibody (1 g/ml, Pharmin-
gen) . A costimulation signal was provided with soluble anti–
human CD28 antibody at a concentration of 1 g/ml
(Pharmingen) . The specificity of the reporter system was
assessed by blocking the activation of the NFAT tran-
scription factor by adding 200 ng/ml of Cyclosporin A
(Sigma) to the culture medium.
Flow Cytometry
Anti -human antibodies against CD3 and CD69 (Phar-
mingen) labeled with phycoerythrin were used. Stained cells
were processed on a FACScan (Becton Dickinson, Franklin
Lakes, NJ) . For the analysis of GFP fluorescence standard
FITC filter settings were used. FACS data were analyzed
with Cell Quest computer software (Becton Dickinson) .
Cytokine Production Assay
IL-2 production was measured after 24-hour incubation
of Jurkat cells at a concentration of 1106 cells /ml in the
absence and presence of PMA, ionomycin, or CD3 and
CD3/CD28 antibodies using ELISA kit DuoSet (R&D
Systems, Minneapolis, MN) following the manufacturer’s
protocols. The cytokine production experiments were per-
formed three times, all determinations were done in
triplicates.
Radiotracer Assay for TKGFP Expression In Vitro
20 - Fluoro - 20 - deoxy - 1 -  -D -arabinofuranosyl -5- iodo-
uracil (FIAU) accumulation assays were performed to
assess the level of TKGFP enzymatic activity in stimulated
and nonstimulated wild- type and transduced Jurkat clones,
as previously described [12] . Briefly, cells were seeded into
six-well tissue culture plates (Falcon, Becton Dickinson)
precoated with anti–human CD3 antibody 1 g/ml (Phar-
mingen) at a concentration of 3106 cells /well. After 24
hours of stimulation, the incubation medium was replaced
with 3 ml of medium containing [2-14C]FIAU 0.01 Ci /ml
(56 mCi /mmol) and [met - 3H]TdR 0.2 Ci /ml (60 Ci /
mmol) (Moravek Biochemicals, Brea, CA). The rest of the
experimental protocol was conducted as previously
described [12] . The ratio of K i values ( the FIAU/TdR ratio)
is a measure of HSV1-tk activity and correlates with other
independent measures of the gene expression [12] .
Subcutaneous Infiltrates, Study Groups, and TCR Stimula-
tion In Vivo
The experimental protocol involving animals was
approved by the Institutional Animal Care and Use Commit-
tee of the Memorial Sloan Kettering Cancer Center. Jurkat
cells (5106 cells of each type) in 100 l of Matrigel
(Collaborative Biochemical Products, Bedford, MA) were
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injected subcutaneously (s.c. ) into 20 nu/nu mice (Harlan
Sprague–Dawley, Indianapolis, IN) weighing 20 to 25 g.
Jurkat cell infiltrates were palpable within 2 weeks and
reached a diameter of about 5 mm in 4 weeks post s.c.
injection.
TCR-mediated activation of the s.c. Jurkat infiltrates was
achieved by IV administration of a purified anti–human CD3
antibody (Antibody Core Facility, Memorial Sloan Kettering
Cancer Center) 250 g/mouse and anti–human CD28
antibody (Pharmingen) 50 g/mouse twice, at 24 and
6 hours before [124I ]FIAU injection. The anti–mouse Ly5.1
antibody (Antibody Core Facility ) was used as a negative
control.
Assessment of TKGFP Fluorescence In Vivo
Whole-body imaging of TKGFP fluorescence in mice was
performed using a home-built digital OFI system consisting
of a 150-W halogen light source LT-9500 (Lightools
Figure 1. Schematic structures and functional properties of the NFAT -TKGFP reporter systems. In SFG-TKGFP, the constitutive expression of the TKGFP reporter
gene is driven by the retroviral LTR. Expression of the TKGFP reporter gene is driven by four tandem repeats of the NFAT - specific DNA binding motif linked to the
minimal E1B promoter in dxNFATtgn, or linked to the minimal CMV promoter in the dcmNFATtgn vector (A ) . FACS profiles of TKGFP reporter gene expression
(TKGFP fluorescence ) under nonstimulated basal conditions ( thin line ) and after stimulation with anti -CD3 antibody ( bold line ) in mixed populations of Jurkat /
dxNFATtgn (B ) and dcmNFATtgn (C ) cells. The basal and stimulated mean fluorescence in Jurkat / dxNFATtgn cells was 30.2 and 71.8, respectively; in
dcmNFATtgn cells the values were 31.4 and 117.4, respectively; the percentage of gated (M1 -GFP positive ) cells is indicated in parentheses. FACS profiles of
TKGFP expression (D ) and ELISA measures of IL - 2 expression (E ) in Jurkat / dcmNFATtgn cells under nonstimulated basal conditions, after stimulation with
anti -CD3 antibody, and after stimulation with anti -CD3 antibody in the presence of Cyclosporin A.
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Research, Encinitas, CA) equipped with an excitation filter
(480 to 490 nm); two fiberoptic guides with linear illumina-
tors (each positioned at 458 ) ; and an emission filter plate
(505-nm cut -off filter; 612 cm). The TKGFP fluorescence
was easily observed with naked eye and the images were
captured using a CCD camera C4742-95-12NR (Hama-
matsu, Bridgewater, NJ) attached to a PC running the MCID
software ( Imaging Research, St. Catharines, Ontario,
Canada) .
PET Imaging with [124I ]FIAU
124I production and [124I ]FIAU synthesis was conducted
as described by us previously [1 ] . One day before
[124I ]FIAU administration, the animals received a 2-ml
intraperitoneal ( i.p. ) injection of a 0.9% NaI solution to
block the thyroid uptake of radioactive iodide (small amounts
of contaminant ) . [ 124I ]FIAU was administered IV 300 Ci/
animal. PET imaging was performed on an advance PET
tomograph (General Electric, Milwaukee, WI) 24 hours after
tracer administration to allow for sufficient clearance of body
background radioactivity. The 24-hour biologic clearance
improved signal - to-noise and specificity of the images.
Animals were anesthetized by i.p. injection of ketamine
(87 mg/kg) and xylazine (13 mg/kg) . Transmission and
emission scans were obtained in 2D mode; the emission
scans were corrected for random counts, dead time, and
attenuation. The duration of the transmission and emission
scans was 15 and 45 minutes, respectively. Images were
reconstructed using the iterative reconstruction algorithm
[13] yielding slice thickness of 4.2 mm and a transaxial
resolution element size of 4 mm2. Radioactivity concen-
tration in tumors (% dose/g) was measured from the PET
images as previously described [1] .
To estimate tumor dosimetry of [ 124I ]FIAU and to confirm
the PET radioactivity measurements, the individual tumors,
muscle, and venous blood were sampled, weighed, and
assayed for 124I radioactivity using a Packard 5500 gamma
spectrometer (Packard, Meriden, CT). A portion of each
infiltrate sample was also used for the assessment of TKGFP
and CD69 expression using FACS.
Statistics
Descriptive statistics of group data were performed using
univariate analysis. Group data were compared using
ANOVA analysis, regression analysis, and Student t test; a
P value of <0.05 was considered significant. Statistical
analysis of data was performed using the StatView 4.57
(Abacus Concepts, Cary, NC).
Results
Assessment of NFAT-TKGFP Reporter System in
Transduced Jurkat Cells
To assess the NFAT-TKGFP reporter system we
developed two self - inactivating retroviral vectors in which
the TKGFP reporter gene was placed under control of two
different artificial NFAT-specific promoters (Figure 1A ).
These promoters contain four NFAT-specific binding site
repeats followed by either the E1b minimal promoter
(dxNFATtgn vector) or the CMV minimal promoter
(dcmNFATtgn vector ) . Jurkat cells transduced with these
vectors were termed Jurkat /dxNFATtgn and Jurkat /
dcmNFATtgn, respectively. Jurkat cells transduced with the
SFG-TKGFP and dxRtgn vectors were termed Jurkat /
TKGFP (positive control ) and Jurkat /Rtgn (negative con-
trol ) , respectively.
The level of the TKGFP expression in a mixed population
of nonstimulated Jurkat /dxNFATtgn cells was similar to that
in wild - type Jurkat cells. Twenty- four hours after stimulation
with either PMA/ ionomycin or anti -CD3 antibody, only
approximately 30% of the Jurkat /dxNFATtgn mixed-cell
population expressed TKGFP at high levels (Figure 1B ) .
Significantly higher levels of TKGFP expression after
stimulation were achieved in a mixed population of Jurkat /
dcmNFATtgn cells, although there was no significant change
in the percentage of reactive cells (Figure 1C ) . There was
no induction of TKGFP expression in Jurkat /Rtgn cells after
stimulation (data not shown).
IL-2 production in mixed populations of both Jurkat /
dxNFATtgn and Jurkat /dcmNFATtgn cells was equally low
Figure 2. NFAT -TKGFP reporter system in dcmNFATtgn clones 3 and 4.
FACS profiles of TKGFP reporter gene expression under nonstimulated basal
conditions and after stimulation with anti -CD3 /CD28 antibodies in clones 3
and 4 of Jurkat / dcmNFATtgn cells. The basal and stimulated mean
fluorescence in clone 3 was 22.9 (A ) and 351.1 (B ) , respectively, and in
clone 4, 25.5 (C ) and 419.1 (D ) , respectively.
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before stimulation and high after stimulation (Figure 1E ) .
The specificity of NFAT-mediated TKGFP and IL-2 expres-
sion was demonstrated by complete inhibition of stimulation
by Cyclosporin A (Figure 1D and E ) .
Jurkat /dcmNFATtgn mixed-population cells were used
further for clonal selection because of higher inducible levels
of the TKGFP. Two single cell–derived clones (3 and 4) of
Jurkat /dcmNFATtgn cells with low background and high
inducible levels of TKGFP expression were obtained
(Figure 2 ) . The dynamics of the dcmNFATtgn reporter
system response was studied at different times (24, 48,
and 72 hours) following stimulation with anti -CD3 alone, or
in combination with anti -CD28 antibodies (Figure 3A ) . The
levels of TKGFP, CD69, and IL-2 expression in Jurkat /
dcmNFATtgn clones were maximal at 24 hours. The level of
TKGFP expression gradually decreased over 72 hours of
continuous stimulation ( in clone 4 more than clone 3) ,
whereas the level of CD69 expression remained high.
Insignificant differences in the magnitude of TKGFP and
CD69 expression in Jurkat /dcmNFATtgn clones were
observed during the 24- to 72-hour period of stimulation
with anti -CD3 alone or in combination with anti -CD28
antibodies. In contrast, significantly higher levels of IL-2
expression were observed after stimulation with the combi-
nation of anti -CD3 and anti -CD28 antibodies, compared
with stimulation by anti -CD3 alone (Figure 3B ) . There were
no detectable levels of TKGFP, CD69 and IL-2 expression
after stimulation with anti -CD28 antibody alone (data not
shown).
The level of TKGFP expression (HSV1-tk subunit
enzymatic activity ) in nonstimulated and stimulated Jurkat /
dcmNFATtgn clones 3 and 4 was additionally assessed
Figure 3. The dynamics of the dcmNFATtgn reporter system response. The FACS profiles of TKGFP reporter gene and CD69 expression in Jurkat / dcmNFATtgn
cells clone 4 under nonstimulated basal conditions and after continuous stimulation with anti -CD3 alone or in combination with anti -CD28 antibodies. The
percentage of gated cells in each quadrant is indicated (A ) . IL - 2 production under nonstimulated basal conditions, and after 24 - hour stimulation with anti -CD3
alone or in combination with anti -CD28 (B ) . The radiotracer FIAU /TdR accumulation ratio before and after stimulation with anti -CD3 /CD28 antibodies in Jurkat /
wild type ( blank ) , Jurkat / dcmNFATtgn clone 3 (shaded ) , clone 4 (solid ) (C ) .
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using a radiotracer assay. The increased levels of TKGFP
expression measured by FACS corresponded with signifi-
cantly higher levels of [ 14C]FIAU accumulation in stimulated
Jurkat /dcmNFATtgn cells, compared with those in non-
stimulated cells (Figure 3C ) . Wild- type Jurkat cells
exhibited only insignificant background levels of [ 14C]FIAU
accumulation.
OFI and PET Imaging of the TKGFP Expression in Jurkat
Cell Infiltrates After CD3 Stimulation In Vivo
The efficacy of the dcmNFATtgn reporter system in vivo
was assessed using OFI and PET. Nude mice bearing four
s.c. infiltrates were studied: Jurkat /dcmNFATtgn clones 3
and 4, Jurkat /TKGFP (positive control ) , and wild- type
Jurkat (negative control ) . Half of the animals (n=10) were
injected IV with anti -CD3 (500 g) and anti -CD28 (100 g)
antibodies to induce the NFAT pathway in Jurkat /TKGFP
infiltrates; the other half were injected with Ly5.1 control
antibody. All animals were injected IV with [124I ]FIAU 24
hours after administration of the antibodies, and imaged 24
hours later with OFI and PET.
OFI images of TKGFP expression obtained in mice before
and after treatment with the control antibody showed no
TKGFP fluorescence in both the Jurkat /dcmNFATtgn and
wild- type Jurkat infiltrates (Figure 4A ) . In animals treated
with the anti -CD3 and anti -CD28 antibodies, a significant
increase of TKGFP fluorescence was observed in Jurkat /
dcmNFATtgn infiltrates (Figure 4B ) . In contrast no TKGFP
fluorescence was observed in wild - type Jurkat infiltrates.
Figure 5. Imaging NFAT-TKGFP reporter system activity with [ 124I ] FIAU and PET and assessments in tissue samples. Photographic image of a typical mouse
bearing different s.c. infiltrates (middle panel ) ; transaxial PET images of TKGFP expression in a mouse treated with control antibody ( left panel ) and anti -CD3 /
CD28 antibodies ( right panel ) were obtained at the levels indicated by the dashed lines (A ) . [ 124I ] FIAU accumulation (% dose /g ) in tissue samples of the Jurkat /
dcmNFATtgn clone 3 and 4 infiltrates, wild - type Jurkat infiltrates, and blood plasma, obtained after PET imaging (B ) . FACS profiles of TKGFP and CD69
expression in a tissue sample from the same Jurkat / dcmNFATtgn clone 4 infiltrate that was imaged with PET (C ) .
Figure 4. Optical fluorescence imaging of the NFAT -TKGFP reporter system
activity in vivo. Images of TKGFP fluorescence in an s.c. Jurkat / dcmNFATtgn
(clone 4 ) infiltrate were obtained in the same animal (A ) before (B ) and
after treatment (C ) with anti -CD3 /CD28 antibodies.
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PET images of [ 124I ]FIAU accumulation obtained in mice
treated with control antibody revealed background levels of
accumulation of [ 124I ]FIAU in both the Jurkat /dcmNFATtgn
and wild- type Jurkat infiltrates (Figure 5A ) . In animals
treated with anti -CD3 and anti -CD28 antibodies, a signifi-
cantly higher accumulation of [ 124I ]FIAU was observed in
the Jurkat /dcmNFATtgn infiltrates. The level of radioactivity
in activated Jurkat /dcmNFATtgn infiltrates was comparable
to that in the constitutively expressing Jurkat /TKGFP
infiltrates (positive control ) (Figure 5B ) .
FACS analysis of the Jurkat /dcmNFATtgn infiltrates
obtained from the Ly5.1 treated animals (noninduced)
animals ( the same animals that were imaged with OFI and
PET) demonstrated base levels of TKGFP and CD69
expression (Figure 5C ) . Similar results were obtained with
the wild- type Jurkat infiltrates (data not shown). In contrast,
the Jurkat /dcmNFATtgn infiltrates from the animals that
were treated with anti -CD3 and anti -CD28 antibodies had a
very large fraction ( >60%) of cells overexpressing both
TKGFP and CD69.
Discussion
The goal of this study was to develop and validate a method
for monitoring the activation and location of T lymphocytes in
vivo using noninvasive imaging techniques. For this purpose,
we generated a TKGFP reporter system that specifically
responds to TCR activation. We constructed and tested two
self - inactivating retroviral vectors bearing an artificial
NFAT-sensitive promoter that controls the expression of
the TKGFP reporter gene. These vectors were used to
establish stably transduced mixed and clonal populations of
Jurkat cells bearing a functional TCR that are frequently used
as a model for T-cell activation [14] . A similar approach
using analogous NFAT-sensitive artificial promoter and GFP
reporter gene was recently described by others [15] .
However, we were not satisfied with inducible levels of
the reporter gene expression that were achievable using
the promoter construct described in the latter study. During
the optimization of our NFAT-sensitive reporter system, we
found that the addition of a minimal CMV promoter
downstream of four tandem repeats of the NFAT-specific
DNA binding sequences (dcmNFATtgn vector) resulted in
significantly higher inducible levels of the reporter gene
expression and only an insignificant increase in background
activity.
The versatility of the TKGFP reporter gene allowed for
assessment of the NFAT-sensitive reporter system activity
by fluorescent microscopy and quantitation by FACS
analysis, as well as radiotracer assay [10,12] and PET
imaging [1] . FACS allowed for the selection of clones of
transduced Jurkat cells with optimal functional character-
istics ( low background and high inducible activity ) .
We demonstrated that the cis-NFAT-TKGFP reporter
system was sufficiently sensitive to image TCR-mediated
anti -CD3 antibody stimulation and correlated with the
expression of two independent markers of T-cell activation,
CD69 and IL-2. The specificity of NFAT-TKGFP reporter
system for TCR-mediated T-cell activation was demonstra-
ted by the absence of an increase in TKGFP expression in
response to the addition of anti -CD28 along with anti -CD3
antibody stimulation, and no TKGFP expression in response
to anti -CD28 antibody stimulation alone. Importantly, the
presence of a functional CD28 costimulatory pathway in
transduced cells was demonstrated by the levels of IL-2
expression obtained in response to the combination of anti -
CD3 and anti -CD28 antibody stimulation, compared to anti -
CD3 alone. As expected, there was no detectable increase in
IL-2 expression in response to anti -CD28 stimulation alone.
Other studies have demonstrated similar results in Jurkat
and primary T cells using a luciferase (Luc) - or GFP-based
reporter system and different stimuli to monitor NFAT
activation [15–17] .
The specificity of our NFAT reporter system was further
confirmed by using Cyclosporin A, which is a commonly used
immunosuppressive drug that acts through inhibiting calci-
neurin-mediated dephosphorylation of NFAT [7] . Cyclo-
sporin A completely inhibited the CD3- and CD28-mediated
activation of the NFAT-TKGFP reporter system, which
further demonstrates the specificity of the NFAT reporter
system. These results are in agreement with previously
published data using a Luc-reporter system, where the Luc-
reporter gene was placed under control of the IL-2 promoter
[17] . The inhibitory effects of Cyclosporin A on TCR-
dependent activation was demonstrated using the IL-2–Luc
system in AAV-transduced Jurkat cells.
A tendency for temporal dissociation in the expression of
TKGFP and CD69 markers for TCR-dependent activation
was observed. Namely, TKGFP expression showed a
tendency to decrease beyond 24 hours of continuous
stimulation in vitro, whereas CD69 expression persisted at
the same level during the 24- to 72-hour period. This
observation may be explained in part by a decrease of NFAT
transcriptional activity as a result of the apoptosis occurring
in stimulated Jurkat cells [18] . The duration of NFAT-
mediated transcriptional activity may actually be even shorter
because the half - life of GFP subunit of TKGFP protein is
about 16 hours [19] and may be shorter than that of CD69.
To further explore this observation, a short - lived variant of
TKGFP reporter protein could be developed using a similar
approach that was previously described for GFP [19] .
An advantage of the TKGFP dual reporter system is that
both fluorescence and nuclear imaging studies can be
performed on the same animal [10] . Whole-body OFI
demonstrating GFP expression has been described in live
mice with s.c. xenografts [20] , in studies of metastatic
tumor spread [21] , neoangiogenesis [22] , and transgenic
animals [5 ] . We have extended OFI to visualize the
NFAT-TKGFP reporter system in transduced Jurkat s.c.
infiltrates. We demonstrated that OFI can be used to
visualize the substantial increase of TKGFP expression in
s.c. Jurkat NFAT-TKGFP infiltrates after stimulation in
vivo. OFI may provide the means for repetitive noninvasive,
semiquantitative temporal monitoring of T-cell activity at
superficial locations (subcutaneous, submucosal, pleural,
peritoneal, etc. ) .
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PET imaging obviates the current limitations of OFI to
imaging superficial lesions. In this report, we have demon-
strated that PET is sufficiently sensitive for visualization of
TKGFP expression (HSV1-tk–derived enzymatic activity )
in NFAT-TKGFP–transduced Jurkat infiltrates. We have
shown that [ 124I ]FIAU and PET imaging can provide spatial
and quantitative information about the process and magni-
tude of TCR-mediated T-cell activation using the NFAT-
TKGFP reporter system. Moreover, the induction of TKGFP
expression correlated with other independent markers of T-
cell activation (e.g., CD69) , and was confirmed by direct
analysis of tissue samples. These combined in vitro and in
vivo results demonstrate that the images of NFAT-TKGFP
reporter system activity obtained with [124I ]FIAU and PET
reflect the status of the TCR-dependent NFAT-mediated
signaling pathway.
Although PET imaging 24 hours after radiotracer
administration is not well suited for T-cell trafficking and
activation studies, recent reports [23,24] and results from
our laboratory [25] show that FIAU imaging can be
performed as soon as 10 to 30 minutes after tracer
administration. Radiolabeling of FIAU with 18F (110 minutes
half - life ) or 11C (20 minutes half - life) is feasible [26,27]
and would provide the opportunity for repetitive imaging
studies.
PET imaging of T- lymphocytic activation using the
NFAT-TKGFP reporter system could potentially be used
to assess efficacy and optimize T-cell doses in immuno-
therapies. For example, in CTL-based therapies (antitu-
mor, antiviral, etc. ) , T cells obtained from a patient could be
transduced with the NFAT-TKGFP reporter system, sensi-
tized against certain antigens, and administered back to the
patient. PET imaging could be performed to visualize the
sites of transduced CTL activation and targeting. Also, it
could be feasible to use the NFAT-TKGFP reporter system
and PET imaging for the assessment of new immunother-
apeutic approaches, including dendritic cell, DNA, RNA and
peptide vaccines, or new immunosuppressive therapies. It
may also find applications in monitoring T-cell involvement
in graft -versus-host-disease after bone marrow trans-
plantation and during the process of organ transplant
rejection.
In summary, we have demonstrated for the first time
that noninvasive OFI and nuclear imaging of T-cell
activation is feasible using the NFAT-TKGFP reporter
system. We have demonstrated that PET imaging with
[124I ]FIAU using the NFAT-TKGFP reporter system is
sufficiently sensitive to detect transcriptional upregulation in
the TCR-dependent NFAT-mediated signal transduction
pathway. PET imaging of TCR- induced NFAT transcrip-
tional activity may be useful in the assessment of T-cell
responses and immunotherapy.
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